跳到正文

医疗相关 ISO 标准准备与证据整理

按指定 ISO 标准组织差距、文件与证据准备,包含医疗器械相关体系资料,实际条文需要取得正式标准。

开源精选医疗业务35 个文件50,135 Stars浏览次数 0K-Dense-AI/scientific-agent-skills MIT版本 a1043ef
开始使用

适用环境:Python 3.11+; bundled CLIs use only the standard library and bounded local JSON/Markdown files, with no network access or credentials.

输入资料
指定标准与组织当前资料 获准使用的标准及证据范围 阅读本节完整说明
交付内容
准备与差距检查资料 证据清单和待完成事项 阅读本节完整说明
  1. 获取完整包,保留配套文件的目录结构。
  2. 按照原文准备所需工具、依赖与输入资料。
  3. 阅读对应使用步骤与输入输出说明,在自己的环境中验证结果。

使用提示摘自原文,配套文件保留来源版本;实际运行条件以各包说明为准。

正文

获取原文件

assets/templates/procedures/document-control-procedure-template.md

STATUS: DRAFT EXAMPLE — NOT APPROVED — NO COMPLIANCE CLAIM

This structure is not a released procedure. It does not determine retention, regulatory applicability, conformity, or certification. Authorized management, RA/QA, legal/regulatory, process owners, and document control must approve the organization-specific controls. ISO publications are copyrighted; use an authorized copy and do not paste their text here.

Controlled-document metadata

Field Entry
Document ID/revision <ID> / <revision>
Owner <accountable role>
Status draft / in-review / approved
Effective date <YYYY-MM-DD after approval>
Evidence repository <controlled location>
Change/superseded record <IDs>
Approval role Named approver Status Date Approval evidence
Process owner <name/role> pending <date> <ID>
RA/QA <name/role> pending <date> <ID>
System owner <name/role> pending <date> <ID>

1. Purpose, scope, and interfaces

  • Controlled documents covered: <types, systems, sites, products>
  • Records covered: <types, systems, sites, products>
  • External sources covered: standards, regulations, guidance, customer and supplier specifications, and product-specific sources.
  • Interfaces: change control, training, validation, data integrity, cybersecurity, supplier controls, product files, complaints/CAPA, audit, and management review.

2. Roles and segregation of duties

Role Authority/responsibility Independence or access restriction Delegate Evidence Approval
Document owner <entry> <entry> <role> <ID> <ID>
Record owner <entry> <entry> <role> <ID> <ID>
Reviewer <entry> <entry> <role> <ID> <ID>
Approver <entry> <entry> <role> <ID> <ID>
System administrator <entry> <entry> <role> <ID> <ID>

3. Document lifecycle

Stage Required controls Owner Status Evidence Approval
Request/authoring need, scope, source/version, author <role> draft <ID> <ID>
Review technical, process, RA/QA, linked-document impact <role> draft <ID> <ID>
Approval/release named authority, date, revision, effective date <role> draft <ID> <ID>
Distribution/use access, point-of-use revision, copy status <role> draft <ID> <ID>
Change rationale, impact, validation/training, linked updates <role> draft <ID> <ID>
Obsolescence withdrawal, archive, retained-copy identification <role> draft <ID> <ID>

Define approved rules for identifiers, revision schemes, emergency changes, printed copies, translations, electronic signatures, and controlled exports. Do not assume that a downloaded or printed file remains controlled.

4. Record lifecycle and data integrity

Control Organization-specific method Owner Status Evidence Approval
Creation/attribution <entry> <role> draft <ID> <ID>
Legibility/completeness <entry> <role> draft <ID> <ID>
Contemporaneous entry <entry> <role> draft <ID> <ID>
Corrections/audit trail <entry> <role> draft <ID> <ID>
Access/security <entry> <role> draft <ID> <ID>
Backup/recovery <entry> <role> draft <ID> <ID>
Retrieval <entry> <role> draft <ID> <ID>
Retention/disposition <entry> <role> draft <ID> <ID>

Retention periods must cite an approved basis for each record type. This template does not supply a universal period.

5. External source and version control

Source ID Publisher/title Version/date Authorized location Applicability owner Last currency review Impact record Status Approval
<ID> <entry> <entry> <entry> <role> <date> <ID> review-due <ID>

Required controls:

  1. Obtain standards from an authorized source and preserve license restrictions.
  2. Record the exact edition/version incorporated into each jurisdictional basis.
  3. Monitor official publishers; do not rely on search snippets as controlled text.
  4. Perform and approve impact assessment before changing QMS documents.
  5. Distinguish ISO, FDA QMSR/eCFR, MDSAP, EU MDR/IVDR/MDCG, and product-specific sources rather than treating them as interchangeable.

6. Electronic systems and software validation

System/use Intended use Risk basis Access/audit-trail controls Validation evidence Change/revalidation trigger Owner Approval
<system> <entry> <entry> <entry> <ID> <entry> <role> <ID>

Do not release an electronic workflow until authorized owners approve intended use, validation evidence, access roles, data migration, backup/recovery, and change controls.

7. Change and training impact

Every change record should include:

  • reason, affected products/sites/processes/documents/records;
  • source/version and regulatory-impact review;
  • risk, validation, software, supplier, and postmarket impacts;
  • training population and completion evidence before effective use;
  • implementation verification, owner, status, evidence, and approval.

8. Registers and audit evidence

Register Owner Status Location Review frequency/basis Evidence Approval
Master document list <role> draft <location> <basis> <ID> <ID>
Record retention schedule <role> draft <location> <basis> <ID> <ID>
External source ledger <role> draft <location> <basis> <ID> <ID>
Access/role register <role> draft <location> <basis> <ID> <ID>
Training/change register <role> draft <location> <basis> <ID> <ID>
Obsolete/disposition log <role> draft <location> <basis> <ID> <ID>

Release checklist

  • Scope includes documents, records, external sources, and electronic systems.
  • Owners, statuses, evidence, source versions, and approvals are explicit.
  • Access, integrity, retrieval, retention, disposition, and audit trails are defined.
  • Change, validation, software, supplier, and training impacts are linked.
  • No universal retention period or automatic applicability conclusion is asserted.
  • No template or script result is described as compliance or certification.
  • Required human approvals are complete before the effective date.

CONTACT HAONAN

联系haonan

医疗 AI · 产品与独立开发

刘浩南

关注医疗 AI 从 demo 到真实落地,聚焦产品化、商业化与院内工作流效率提升。

12年医疗产研经验,大湾区头部医疗AI公司前产品总监,独立开发者

医疗 AI 产品化医疗 AI 商业化院内工作流效率
刘浩南的微信联系二维码
微信扫一扫,联系 haonan